Federal Register of Legislation - Australian Government

Primary content

PB 63 of 2020 Determinations/Health as made
This determination amends the National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) (PB 81 of 2017) by removing one specified form of the drug diazepam from the exempt list.
Administered by: Health
Registered 30 Jun 2020



PB 63 of 2020

National Health (Pharmaceutical Benefits Scheme- Exempt items - Section 84AH) Amendment Determination 2020 (No. 2)

National Health Act 1953

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 84AH of the National Health Act 1953.

Dated  29  June 2020





Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health


1              Name of Instrument

(1)      This instrument is the National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination 2020 (No. 2).

(2)     This instrument may also be cited as PB 63 of 2020.

2              Commencement

                This instrument commences on 1 July 2020.

3              Amendments to PB 81 of 2017

The Schedule amends the legislative instrument titled National Health (Pharmaceutical Benefits Scheme–Exempt items – Section 84AH) Determination 2017 (PB 81 of 2017)

Schedule                      Amendments



[1]  In the Schedule , after entry for Clonazepam, Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)




Injection 10 mg in 2mL